课题基金 / 基金详情

Mitigating the risk of micropollutants in the environment

Mitigating the risk of micropollutants in the environment
减轻环境中微污染物的风险
批准号:
EP/I025782/1
负责人:
Russell Davenport
金额:
$142.0万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Russell Davenport的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The vision of this research is to achieve a chemical safe world where the benefits of modern products and processes can be enjoyed by all without undue detriment to the planetary ecosystem on which all life depends. It aims to improve our understanding and prediction of a key uncertainty (i.e. microbial biotransformation) that underpins ways in which society can reduce the risks posed by potentially hazardous chemicals to environmental and human health. Such chemicals are manufactured and present in many everyday products that benefit the health and well-being of consumers world-wide, and the economic prosperity and productivity of societies, examples include: personal care, domestic and hygiene products; pesticides; pharmaceuticals; and plastics. Environmental and human exposure to these chemicals can occur throughout the life cycle of a product; from its manufacture, distribution and use, to exposure after disposal and breakdown of the product. There has been widespread concern about the pervasive use of chemicals and their potential dangerous side-effects on wildlife and humans ever since Rachel Carson's landmark book in 1962 about the environmental hazards of the pesticide DDT. For instance, the 'feminising' effects on fish populations caused by low concentrations of natural and synthetic estrogens (e.g. in the contraceptive pill) and their chemical mimics (so-called micropollutants) is well publicised. It is widely suspected, though not proven, that many micropollutants are linked to cancers, reproductive and developmental diseases in humans. In fact there has been a relative rise in the incidence of such chronic diseases in the last two decades, making them surpass infectious diseases as the biggest global killer. These facts together with other case studies of environmental, occupational and consumer hazards, have led the European Union to enact the precautionary principle in a number of comprehensive legislative directives including chemical regulation and management of the water environment to protect the environment and human health. Analysis has shown that the benefit of such measures far out way their costs.The ways in which we can reduce risks to these chemicals are: i) by identifying hazardous chemicals and restricting their manufacture, distribution and use more effectively - so called chemical regulationii) by improving engineered technologies to remove hazardous chemical pollutants when they are released into the environment e.g. wastewater treatment worksiii) designing chemicals that have no hazardous properties - so called green chemicals . Microbial biotransformations, such as biodegradation by bacteria, play a direct and key role in each of these risk reduction strategies. In chemical regulation (i above), biodegradation is one of the most important factors in determining the extent and likelihood that a given chemical will persist in the environment (air, water, soil and sediment) and therefore the likely concentration to which wildlife and humans will be exposed. Known hazardous (toxic) chemicals tend to persist longer than non-hazardous ones. Biodegradation is also a central process in which many engineered technologies remove chemical pollutants (ii above). We also need to evaluate biodegradation in order to understand what chemical structures are resistant to biodegradation, and thereby avoid their use in the design of new products (iii above). This research has two objectives towards providing greater certainty and improvements in risk mitigation strategies:1. To build a world class team to tackle this challenging issue.2. To discover the fundamental rules that govern micropollutant biotransformation through case studies.The research will benefit policy-makers, governmental regulatory agencies, the chemical and water industries, and eventually the whole of society as this scientific understanding improves ways in which chemical risks are managed.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s11356-013-2064-4
发表时间: 2014
期刊: Environmental science and pollution research international
影响因子: --
作者: [Goodhead AK, Head IM, Snape JR, Davenport RJ]
通讯作者: Davenport RJ
The experimental determination of reliable biodegradation rates for mono-aromatics towards evaluating QSBR models.
通过实验确定单芳烃的可靠生物降解率,以评估 QSBR 模型。
DOI: 10.1016/j.watres.2019.05.075
发表时间: 2019
期刊: Water research
影响因子: 12.8
作者: [Acharya K]
通讯作者: Acharya K
DOI: 10.1002/ieam.4575
发表时间: 2022-11
期刊: INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT
影响因子: 3.1
作者: [Davenport, Russell, Curtis-Jackson, Pippa, Dalkmann, Philipp, Davies, Jordan, Fenner, Kathrin, Hand, Laurence, McDonough, Kathleen, Ott, Amelie, Ortega-Calvo, Jose Julio, Parsons, John R., Schaffer, Andreas, Sweetlove, Cyril, Trapp, Stefan, Wang, Neil, Redman, Aaron]
通讯作者: Redman, Aaron
DOI: --
发表时间: 2018
期刊:
影响因子: --
作者: [Garci C]
通讯作者: Garci C
6
    Experimental Biology and Engineering at the Pilot Scale - Strategic Equipment
    • 批准号:
      EP/P001564/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $152.48万
    • 财政年份:
      2016
    • 负责人:
      Russell Davenport
    • 依托单位:
    Engineering the household removal of micropollutants from wastewater
    • 批准号:
      EP/M017737/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $33.41万
    • 财政年份:
      2014
    • 负责人:
      Russell Davenport
    • 依托单位:
    国内基金
    海外基金
    The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
    面向人工智能生成内容的风险识别与治理策略研究
    • 批准号:
      72304290
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30.00万元
    • 批准年份:
      2023
    • 负责人:
      向安玲
    • 依托单位:
    基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
    • 批准号:
      82371912
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      吴广宇
    • 依托单位:
    基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
    • 批准号:
      81973152
    • 项目类别:
      面上项目
    • 资助金额:
      54.0万元
    • 批准年份:
      2019
    • 负责人:
      胡东生
    • 依托单位: